InvestorsHub Logo
Followers 0
Posts 820
Boards Moderated 0
Alias Born 09/04/2019

Re: None

Wednesday, 12/02/2020 4:21:01 PM

Wednesday, December 02, 2020 4:21:01 PM

Post# of 20803
FYI,

Current OTC for CLSID/OBOCON LLC/INC. research identifies the following information.

March 3, 2020 Form 8k. (OTC-DISCLOSURE & NEWS SOURCE)
Effective or prior to January 30, 2020 Board of Directors appointed Naveen Doki Chairman of the board and CEO of the company, all previously resigned from the company.

March 12 2020 From 8k. (OTC-DISCLOSURE & NEWS SOURCE)
CLSI entered into stock purchase agreement with Hyperion. (Contract not consummated. Contact Information: Sam Mathew Phone (248) 982-0734.

May 27, 2020 From 8k. (OTC-DISCLOSURE & NEWS SOURCE)
The company (CLSI) has terminated stock purchase agreement with Hyperion immediately by Naveen Doki, CEO CLSI.

June 2020. (OTC-DISCLOSURE & NEWS SOURCE)
PINK CURRENT INFORMATION - 06/2020 VERIFIED PROFILE. (CLSI is now Pink Compliant).

July 8 2020 (OTC-DISCLOSURE & NEWS SERVICE)
Stephen Mills is retained as acting counsel for CLSI, and Reports Annual Disclosures for 2019 to the OTC. (First time).

June 30 2020. (OTC-DISCLOSURE & NEWS SERVICE)
CLSI to Acquire OBOCON LLC (NOT, INC)
Investor Contact: Suresh Venkat / Phone (703) 310-7334
Email: investor.relations@obocon.com

July 13 2020. (OTC-DISCLOSURE & NEWS SERVICE)
CLSI/OBOCON Signed an Agreement to Acquire Anthea Inc.
Investor Contact: Suresh Venkat / Phone (703) 310-7334
Email: investor.relations@obocon.com

July 21 2020. (OTC-DISCLOSURE & NEWS SERVICE)
CLSI Announces Global Distribution Agreement with Roast Foods.
Investor Contact: Suresh Venkat / Phone (703) 310-7334
Email" investor.relations@obocon.com

August 14 2020. (OTC-DISCLOSURE & NEWS SERVICE)
CLSI Consummated the acquisition of the controlling interest of Anthea Inc. for 60,000,000 shares of company common stock.
Investor Contact: Suresh Venkat / Phone (703) 310-7334

August 15 2020. (OTC-DISCLOSURE & NEWS SREVICE)
Stephen Mills acting counsel for CLSI reports Annual Disclosure for 2019 to the OTC. (Second time).

August 30 2020. (OTC-DISCLOSURE & NEWS SERVISCE)
CLSI Company Financial Report.
Number of common shares as of September 30th, 2020 was; 350,597, 655.
(OTC Markets Group Inc. October 16th, 2020)

November 19 2020. (OTC-DISCLOSURE & NEWS SERVICE)
Symbol Change from CLSI to CLSI"D".

November 19 2020. (OTC-DISCLOSURE & NEWS SERVISE)
Capital Change = SHS decreased by 1 for 10 split.
EX-DATE = 11/19/2020. PAY DATE = 11/19/2020.


COMPANY LOCATION AND OFFICER(S) AS OF 12/2/2020. (OTC-DISCLOSURE & NEWS SERVICE).

CLSID / OBOCON INC. (NOT LLC), AS REPORTED ON 6/30/2020).

Address: OBOCON INC. 4902 FINCHEM CT. FAIRFAX, VA 22030
Email: www. clancysystems.com / clancy@clancysystems.com

COMPANY OFFICERS & CONTACTS:
Naveen Doki (CEO)

Scott C. Kline (Counsel)

SERVICE PROVIDER(S):
Stephen Mills Attorney At Law
Nashville TN. 37228


So, Since the OTC is "LAW" here, these are the facts pertaining to CLSID / OBOCON (LLC-INC) per the OTC.

If anyone else here has anything to add, please feel free. There has been so much disinformation posted here on this board, so I felt we needed a new starting point of origin as of 12/2/2020.

Additionally, Sam Mathew was only mentioned once for contact information, and is not identified in the "COMPANY OFFICER or CONTACT" profile.

While Suresh Venkat was mentioned three times and when I personally questioned him, he stated he knew nothing about CLSI /OBOCON, but again, he is listed as CLSID / OBOCON's investor relations contact.

GO-CLSID/OBOCON (LLC-INC)?
GO-DR.DOKI
GO-SAM???